News - Lonza

Filter

Current filters:

Lonza

Popular Filters

Pharmacyclics signs deal with Lonza to support manufacturing of Imbruvica

Pharmacyclics signs deal with Lonza to support manufacturing of Imbruvica

13-01-2014

USA-based Pharmacyclics has signed a deal with Swiss chemical supplier Lonza for the commercial and clinical…

ImbruvicaLonzaOncologyPharmaceuticalPharmacyclicsProductionUSA

Lonza and BioWa sign research agreement with Pfizer

30-07-2013

Swiss chemicals and drug company Lonza (SIX: LONN) and USA-based BioWa, a wholly-owned subsidiary of…

Asia-PacificBiotechnologyLonzaPfizerResearch

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Switzerland's Lonza involvement in South Africa pharma project in doubt

28-05-2013

The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

Ipsen expects Increlex supply interruption; 1st-qtr sales up 5.3%

25-04-2013

French drugmaker Ipsen (Euronext: IPN) says that its supplier of Increlex (mecasermin [rDNA origin] Injection)…

FinancialIncrelexIpsenLonzaPharmaceuticalProduction

Lonza to invest in new antibody drug conjugate manufacturing capacity to meet growing demand

08-01-2013

Swiss pharmaceutical ingredients and specialty chemicals firm Lonza (SIX: LONN) plans to invest 14 million…

BiotechnologyFinancialLonzaOncologyProduction

Avalanche Biotech and Lonza link up on adeno-associated viral vectors for gene therapy

16-05-2012

Privately-held US firm Avalanche Biotechnologies and Switzerland-based contract manufacturer Lonza (SIX:…

Avalanche BiotechnologiesBiotechnologyLonzaOphthalmicsResearch

Lonza and Agennix link up for talactoferrin production

12-04-2012

Switzerland-based Lonza (SIX: LONN) and Agennix AG (FSE: AGX) of Germany have announced an agreement…

AgennixBiotechnologyLonzaOncologyPharmaceuticalResearchtalactoferrin

Mesoblast and Lonza establish strategic global manufacturing alliance for stem cell products

28-09-2011

Australian regenerative medicine company Mesoblast (ASX: MSB) and Switzerland-based Lonza Group (SWS:…

BiotechnologyLicensingLonzaMesoblastPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top